Periodontal Pocket Clinical Trial
Official title:
Investigation of the Safety and Efficacy of a Periodontal In-situ Gelling Product, Pocket-X Gel, in the Treatment of Periodontal Pockets Following Scaling and Root Planing
NCT number | NCT03358251 |
Other study ID # | PX-01 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 12, 2018 |
Est. completion date | December 30, 2019 |
Verified date | August 2020 |
Source | Tree of Life Pharma Ltd. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is an open-label split-mouth study in which Pocket-X Gel, a periodontal in-situ gelling product, will be applied to periodontal pockets in one/two mouth segment(s) of participants, following scaling and root planing on the entire mouth, while the contralateral segment(s) will serve as control. The aim of the study is to investigate the safety and efficacy of Pocket-X Gel in improving the healing of the gingiva and preventing bacterial re-colonization in the periodontal pocket following scaling and root planing.
Status | Completed |
Enrollment | 34 |
Est. completion date | December 30, 2019 |
Est. primary completion date | December 30, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Provision of signed and dated informed consent form 2. Male or female, aged 18 and above 3. Provision of up-to-date full mouth periapical x-rays 4. Participants suffering from active moderate to severe chronic periodontitis with at least 3 sites of periodontal pockets of 5 mm or greater depth in each quadrant. 5. Participants with a minimum of 6 teeth with periodontal pocket depth of more than 5 mm. 6. Participants with a minimum of 20 teeth Exclusion Criteria: 1. Known hypersensitivity to any of the devices components as listed on the user leaflet 2. Pregnancy or lactation 3. Smoking of more than 9 cigarettes per day 4. A concurrent dental disease, except for periodontitis, or planned treatment that may interfere with the study or study intervention, such as dental surgery, teeth implantation, etc. 5. Chronic disease such as diabetes mellitus or rheumatoid arthritis 6. Aggressive periodontitis 7. History of radiotherapy or chemotherapy 8. Immunodeficiency or autoimmune disease 9. Mental disorders 10. Parafunctional habits such as bruxism 11. Participant has taken antibiotics in the 6 months prior to the study 12. Participant has undergone periodontal treatment 12 months prior to the study |
Country | Name | City | State |
---|---|---|---|
Israel | Dr. Ariel Hirsch Periodontal Clinic | Tel Aviv | |
Israel | Dr. Roni Kolerman Periodontal Clinic | Tel Aviv |
Lead Sponsor | Collaborator |
---|---|
Tree of Life Pharma Ltd. |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Periodontal Pockets Probing Depth | Change in the probing depth of periodontal pockets which have undergone treatment with SRP+Pocket-X Gel in comparison to periodontal pockets which have undergone SRP only. | 12 and 24 weeks following first Pocket-X Gel administration | |
Secondary | Change in Clinical Attachment | Change in the clinical attachment level of mouth segments which have undergone treatment with SRP+Pocket-X Gel in comparison to mouth segments which have undergone SRP only. | 12 and 24 weeks following first Pocket-X Gel administration | |
Secondary | Change in Recession Level | Change in gingival recession level (buccal) of mouth segments which have undergone treatment with SRP+Pocket-X Gel in comparison to mouth segments which have undergone SRP only. Measured in mm. | 12 and 24 weeks following first Pocket-X Gel administration | |
Secondary | Change in Bleeding Index | Change in gingival bleeding index of mouth segments which have undergone treatment with SRP+Pocket-X Gel in comparison to mouth segments which have undergone SRP only. | 12 and 24 weeks following first Pocket-X Gel administration | |
Secondary | Change in Mobility Grade | Change in mobility grade of teeth present in mouth segments which have undergone treatment with SRP+Pocket-X Gel in comparison to mouth segments which have undergone SRP only. Mobility is graded clinically by applying pressure with the ends of 2 metal instruments (e.g. dental mirrors) and trying to rock a tooth gently in a bucco-lingual direction (towards the tongue and outwards again). Normal, physiologic tooth mobility of about 0.25 mm is present in health. This is because the tooth is not fused to the bones of the jaws, but is connected to the sockets by the periodontal ligament. Abnormal, pathologic tooth mobility occurs when the attachment of the periodontal ligament to the tooth is reduced (attachment loss), or if the periodontal ligament is inflamed. Tooth mobility is measured and graduated from 0-3. Grade 0: No apparent mobility Grade 1: Perceptible mobility <1mm in buccolingual direction Grade 2: >1mm but <2mm Grade 3: >2mm or depressibility in the socket |
12 and 24 weeks following first Pocket-X Gel administration |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04712630 -
Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft
|
N/A | |
Recruiting |
NCT03997552 -
NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration
|
N/A | |
Completed |
NCT05908929 -
PRF Therapy for Pocket Reduction
|
N/A | |
Recruiting |
NCT05722509 -
Evaluation of a New Technique for Periodontal Pocket Reduction in the Extraction of Wisdom Teeth
|
N/A | |
Completed |
NCT05631600 -
Manuka Honey as an Adjunct to Non-surgical Periodontal Therapy: Clinical Study
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT03588507 -
Clinical and Radiographic Evaluation of PPF With or Without NCHA Bone in Treatment of Intrabony Defects
|
N/A | |
Recruiting |
NCT06123000 -
Modified Widman Flap vs Fibre Retention Osseous Resective Surgery
|
N/A | |
Completed |
NCT06200415 -
Glucosamine Sulphate Versus Ginger in Non-Surgical Periodontal Therapy
|
Phase 2 | |
Completed |
NCT03364751 -
Effect of Switching From Cigarette Smoking to the Use of IQOS on Periodontitis Treatment Outcome
|
N/A | |
Terminated |
NCT04639661 -
Predictors of Periodontal Outcomes Post-sanative Therapy
|
||
Enrolling by invitation |
NCT05125835 -
Periodontal Maintenance and the COVID-19 Pandemic
|
||
Not yet recruiting |
NCT06050863 -
Local Delivery of Silk Fibroin and Chlorhexidine
|
Phase 1 | |
Not yet recruiting |
NCT03909568 -
Bone Height and Extractions Study
|
N/A | |
Completed |
NCT05162417 -
Photodynamic in Periodontal Treatment
|
N/A | |
Completed |
NCT05803031 -
Efficacy of Locally Delivered Tea Tree Oil Gel as an Adjunct to Non-Surgical Periodontal Management
|
N/A | |
Recruiting |
NCT05533528 -
Periodontal Granulation Tissue Preservation in Surgical Periodontitis Treatment
|
N/A | |
Not yet recruiting |
NCT06309719 -
Hyaluronic Acid and Polynucleotides for Supra-bony Defects
|
N/A | |
Completed |
NCT02630173 -
Evaluation of Endodontic Status on Periodontal Healing of Concomitant Endodontic Periodontal Lesions
|
N/A | |
Completed |
NCT02627326 -
Chlorhexidine Intracanal Medicament in Periodontal Healing in Concomitant Endo Perio Lesion With Communication
|
Phase 2 | |
Completed |
NCT04082949 -
Autologous Fibrin Glue Application as an Adjunct to Nonsurgical Periodontal Treatment of Chronic Periodontitis
|
Early Phase 1 |